Investor profile
Hemex has backed 4 European tech companies across 5 funding rounds between 2020 and 2025, joining rounds totalling €17M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Hemotune AG | Switzerland | 1 | €7.1M |
| Aspivix | Switzerland | 1 | €4.8M |
| Bottneuro | Switzerland | 1 | €4.1M |
| Annaida Technologies | Switzerland | 2 | €928k |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Hemotune AG | Series B | €7.1M | 2022-04 |
| Aspivix | Series A | €4.8M | 2022-11 |
| Bottneuro | Other | €4.1M | 2022-12 |
| Annaida Technologies |
| Seed |
| €928k |
| 2020-09 |
